CURIS, INC. Marketable Securities (Current)
CURIS, INC. (CRIS) had Marketable Securities (Current) of $0 as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-03-31
- 2024-12-31: Marketable Securities, Current $0.00.
- 2024-09-30: Marketable Securities, Current $0.00.
- 2024-06-30: Marketable Securities, Current $18.36M.
- 2024-03-31: Marketable Securities, Current $10.76M.
| Period end | Marketable Securities, Current | Marketable Securities, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $18.36M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $10.76M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $29.65M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $44.03M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $43.66M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $40.06M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $65.97M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $68.84M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $73.19M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $102.19M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $75.87M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $38.88M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $153.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $153.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $5.11M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $6.65M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $8.10M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $30.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $634.00K 10-K · filed 2020-03-19 | |
| 2018-09-30 | $5.27M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $9.96M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $23.72M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $21.94M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $19.39M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $24.36M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $18.39M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $18.45M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $32.68M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $53.03M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $58.43M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $49.10M 10-K · filed 2017-03-09 | $49.10M 10-K · filed 2016-02-29 |
| 2015-09-30 | $64.81M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $67.70M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $76.49M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $42.00M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $46.67M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $45.61M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $49.86M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $48.59M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $49.44M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $47.39M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $40.78M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $42.79M 10-K · filed 2014-03-13 | |
| 2012-06-30 | $32.62M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $30.35M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $22.60M 10-K · filed 2013-03-13 | |
| 2011-09-30 | $16.47M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $25.93M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $32.55M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |